General Anesthesia Versus Loco-Regional Anesthesia for Transcarotid Trancatheter Aortic Valve Replacement
Launched by UNIVERSITY HOSPITAL, CAEN · Mar 6, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different types of anesthesia used during a procedure called transcarotid transcatheter aortic valve replacement (TAVR), which is a treatment for a heart condition known as aortic stenosis. Specifically, the trial will compare locoregional anesthesia, which numbs a specific area of the body, to general anesthesia, which puts the patient completely to sleep. The goal is to find out which method is better for patients undergoing this procedure.
To be eligible for this trial, participants must be adults who have had a transcarotid TAVR at the University Hospital of Caen between October 2021 and December 2024. Anyone who does not want their data collected or does not have information about the main goals of the study will not be included. While the trial is not yet recruiting participants, those who take part can expect to contribute to important research that may help improve anesthesia options for future patients undergoing this heart procedure.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients who underwent a transcarotid TAVR at the University Hospital of Caen between October 2021 (when the first TAVR was performed under locoregional anesthesia) and December 2024
- Exclusion Criteria:
- • Patient's refusal to allow data collection and lack of data regarding the primary endpoint
About University Hospital, Caen
The University Hospital of Caen is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent center for medical education and patient care in Normandy, France, it integrates cutting-edge scientific inquiry with compassionate clinical practice. The hospital collaborates with multidisciplinary teams to conduct rigorous studies aimed at improving treatment outcomes across various medical specialties. By fostering a collaborative environment, the University Hospital of Caen plays a pivotal role in translating research findings into effective therapeutic strategies, ultimately enhancing patient care and contributing to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported